Douglas L. Boggs

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Douglas L. Boggs, Toral Surti, Aarti Gupta et al. · Psychopharmacology · 2018 · 224 citations

Cannabis Use, Psychopathology, Psychiatry +13

Cigarette Smoking and Mortality Risk in People With Schizophrenia

Deanna L. Kelly, Robert P. McMahon, Heidi J. Wehring et al. · Schizophrenia Bulletin · 2009 · 156 citations · Full text

Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers

Kenneth H. Levin, Marc L. Copersino, Stephen J. Heishman et al. · Drug and Alcohol Dependence · 2010 · 147 citations

Cannabis Use, Substance Abuse, Substance Use +7

Diagnostic criteria for cannabis withdrawal syndrome

David A. Gorelick, Kenneth H. Levin, Marc L. Copersino et al. · Drug and Alcohol Dependence · 2011 · 116 citations · Full text

Cannabis Use, Substance Abuse, Substance Use +9

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

Robert W. Buchanan, Julie Kreyenbuhl, Deanna L. Kelly et al. · FOCUS The Journal of Lifelong Learning in Psychiatry · 2012 · 83 citations

Psychiatric Evaluation, Psychotropic Medication, Psychopharmacology +17